Cooper EBITDA Margin 2010-2024 | COO

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cooper (COO) over the last 10 years. The current EBITDA margin for Cooper as of January 31, 2024 is .
Cooper EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-01-31 $3.67B $0.91B 24.85%
2023-10-31 $3.59B $0.90B 25.05%
2023-07-31 $3.51B $0.86B 24.59%
2023-04-30 $3.43B $0.84B 24.51%
2023-01-31 $3.38B $0.88B 26.01%
2022-10-31 $3.31B $0.85B 25.79%
2022-07-31 $3.22B $0.87B 26.93%
2022-04-30 $3.14B $0.83B 26.28%
2022-01-31 $3.03B $0.82B 27.07%
2021-10-31 $2.92B $0.82B 27.92%
2021-07-31 $2.85B $0.79B 27.65%
2021-04-30 $2.66B $0.75B 28.18%
2021-01-31 $2.47B $0.63B 25.39%
2020-10-31 $2.43B $0.60B 24.64%
2020-07-31 $2.44B $0.64B 26.18%
2020-04-30 $2.54B $0.71B 27.89%
2020-01-31 $2.67B $0.83B 31.07%
2019-10-31 $2.65B $0.83B 31.21%
2019-07-31 $2.61B $0.80B 30.77%
2019-04-30 $2.59B $0.78B 29.92%
2019-01-31 $2.57B $0.70B 27.30%
2018-10-31 $2.53B $0.68B 26.81%
2018-07-31 $2.44B $0.64B 26.28%
2018-04-30 $2.34B $0.62B 26.38%
2018-01-31 $2.23B $0.64B 28.52%
2017-10-31 $2.14B $0.62B 28.89%
2017-07-31 $2.10B $0.58B 27.86%
2017-04-30 $2.06B $0.58B 28.03%
2017-01-31 $2.02B $0.55B 27.32%
2016-10-31 $1.97B $0.52B 26.58%
2016-07-31 $1.91B $0.49B 25.88%
2016-04-30 $1.85B $0.45B 24.03%
2016-01-31 $1.80B $0.42B 23.46%
2015-10-31 $1.80B $0.43B 23.80%
2015-07-31 $1.81B $0.42B 23.09%
2015-04-30 $1.78B $0.44B 24.89%
2015-01-31 $1.76B $0.45B 25.50%
2014-10-31 $1.72B $0.45B 25.92%
2014-07-31 $1.66B $0.46B 27.51%
2014-04-30 $1.64B $0.45B 27.61%
2014-01-31 $1.61B $0.44B 27.53%
2013-10-31 $1.59B $0.43B 27.14%
2013-07-31 $1.57B $0.45B 28.44%
2013-04-30 $1.54B $0.43B 27.76%
2013-01-31 $1.50B $0.41B 27.15%
2012-10-31 $1.45B $0.40B 27.34%
2012-07-31 $1.41B $0.38B 26.81%
2012-04-30 $1.38B $0.35B 25.31%
2012-01-31 $1.36B $0.34B 25.09%
2011-10-31 $1.33B $0.33B 24.51%
2011-07-31 $1.28B $0.32B 24.88%
2011-04-30 $1.23B $0.32B 25.84%
2011-01-31 $1.19B $0.30B 24.85%
2010-10-31 $1.16B $0.28B 24.53%
2010-07-31 $1.13B $0.27B 23.49%
2010-04-30 $1.12B $0.25B 22.02%
2010-01-31 $1.09B $0.25B 22.50%
2009-10-31 $1.08B $0.24B 22.50%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.860B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.42
Align Technology (ALGN) United States $19.244B 37.15
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00